8th October, 2020 - Press notes
A study by researchers from Hospital del Mar and the Hospital del Mar Medical Research Institute reveals the protective effect that 30 minutes of moderate physical activity per day can have, as recommended by the World Health Organisation. Multiplying this figure by four maximises the benefit, but, beyond this, there is no additional benefit. The study, published by the Revista Española de Cardiología (Spanish Journal of Cardiology), has been monitoring over 11,000 people for more than 7 years.
October 2nd, 2020 - Press notes
Benign breast diseases (BBD), which are non-cancerous disorders of the breast, such as lumps, are known to increase the chances of subsequent breast cancer. Now a team of Hospital del Mar researchers have found that the way BBD is detected as part of a national screening programme is an indication of which are more likely to become cancerous.
15/09/2020 - Press notes
This discovery may provide new treatment strategies and therapeutic targets for important diseases such as cancer or Alzheimer's
The research group of GPCR Drug Discovery at the Hospital del Mar Medical Research Institute (IMIM), in collaboration with the Indian Institute of Technology in Kanpur, has deciphered how nature adjusts the response of the human cell to abundant extracellular stimuli (e.g., smell, taste, light, hormones, etc.).September 3rd 2020 - Press notes
Arnau Busquets-García, an IMIM researcher, receives an ERC Starting Grant for scientific excellence.
July 9th 2020 - Press notes
Dr. Arnau Busquets, currently a Ramon y Cajal researcher in the IMIM's Integrated Pharmacology and Systems Neuroscience Research Group is one of the first authors of this work.
June 30th 2020 - Press notes
The successful projects are "Obtaining antioxidant active substances from the carob pod and validating their therapeutic potential", which involves the company Euronutra, the IBIMA (Malaga Biomedical Research Institute), the IMIM (Hospital del Mar Medical Research Institute), and the CRG (Centre for Genomic Regulation); and the project "Development of a new therapy for Fragile X syndrome", in which the company Connecta Therapeutics, the IMIM, and the CRG are participating.
May 28th 2020 - Press notes
The MINDUP project began in January 2020 to support SMEs in the mental health care of their workers. Now adapting to the COVID-19 pandemic and highlighting its usefulness in current circumstances.
May 25th 2020 - Press notes
The company Chemotargets -based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform- has signed a strategic agreement with the Hospital del Mar Medical Research Institute (IMIM) to discovery and development of new oncological therapies that respond to important unmet medical needs.
4th May, 2020 - Press notes
This is the first time that anyone has studied how brain alterations at a functional level in mice with Down syndrome respond to chronic treatment with a component of green tea that we know, from other studies, improves executive functions in adults with Down syndrome.
February 6th 2020 - Press notes
The company, founded today, is backed by IMIM and UPF and is developing products and services based on the DisGeNET platform, one of the tools on the genetics of diseases with most information in the world.
This site complies with the HONcode standard for trustworthy health information: 
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2024 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
